Company Overview

Update
Founded:
2006
Headquarters:
Vancouver
Funding:
$1.1M
Categories:
Hardware + Software
Description:
Verisante Technology is a medical device company committed to commercializing innovative systems for the early detection of cancer.

Detailed Description

Update

The Verisante Aura™ for skin cancer detection and the Verisante Core™ series for lung, colon and cervical cancer detection utilize a proprietary cancer detection platform while the operating software and probe technology are unique to each device. The cancer detection platform was developed by the BC Cancer Agency and the University of British Columbia and tested and refined on approximately 1,000 lesions at the Skin Care Centre at Vancouver General Hospital.

Current Team (2)

Update

Funding Rounds (1) - $1.1M

Update
  • $1.1M / Seed

    Nov 14, 2013

Offices/Locations (1)

Update
  • Office

    306 - 2309 West 41st Avenue

    Vancouver, V6M 2A3

    CAN

Images (2)

Update
  • Iezmq3iqbqbdkl6xajyr
  • Fda3780b19a58492884ece9c06c64387